CalciMedica Inc. Common Stock is a bio-pharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibitors for the treatment of diseases like acute pancreatitis and severe asthma. With its innovative approach, the company aims to revolutionize the treatment landscape and improve patient outcomes.
Notification